-
Applying G-methods to Account for Treatment Switching in Postmarketing Effectiveness Evaluation: A Case Study of GLP-1 Receptor Agonists for Diabetic Kidney Disease
Sep 9, 2025, 16:22 PM -
Cost-Savings Assessment of Fitusiran Prophylaxis in Minimizing Breakthrough Bleeding Treatment Expenses in the United Arab Emirates
Sep 9, 2025, 16:22 PM -
Factors Impacting GKV Rebates for Orphan Drugs (OD) in Germany: A Decision Analysis Using the CRA RADAR Database
Sep 9, 2025, 16:22 PM -
Exploring Meaningful Change in Digital Health Technologies via Qualitative Interviews
Sep 9, 2025, 16:22 PM -
Pharmacoeconomic and Healthcare Aspects of the TDM-Guided Decisions on Biological Treatment of Inflammatory Diseases: Systematic Review of International Evidence
Sep 9, 2025, 16:22 PM -
How Publication Bias May Overestimate the Risk of Serious Adverse Events Associated With Bisphosphonate Use
Sep 9, 2025, 16:22 PM -
Potential Implications of EU Joint Clinical Assessment (JCA) for the UK Affiliate of a Global Pharmaceutical Company
Sep 9, 2025, 16:22 PM -
Systematic Review of Effectiveness of SGLT2 Inhibitors in Patients With Type 2 Diabetes With Focus on Glucose Levels, Cardiovascular Events, and Renal Function
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Familial Hypercholesterolemia Cascade Testing in Thailand: A Comparative Analysis of Exome vs. Long-Read DNA Sequencing
Sep 9, 2025, 16:22 PM -
The Impact of Using England Real-World Evidence to Establish the NICE Severity Modifier in Metastatic Urothelial Carcinoma (MUC)
Sep 9, 2025, 16:22 PM -
Is Europe and European Evidence Development an Afterthought in Pharmaceutical Early Stage Development Decisions? An Exploratory Qualitative Survey
Sep 9, 2025, 16:22 PM -
Patient Perspectives on Disease Experiences and Value of Real-Time Self-Reported Symptom and Treatment Monitoring in Locally Advanced and Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Impact of Dupilumab on Mental Health Service Utilization in Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Systematic Review of Doubly Robust Methods for Population-Adjusted Indirect Comparisons
Sep 9, 2025, 16:22 PM -
Focus on Two Years of Economic Opinions on Solid Cancers (2023-2024): What Are the Specific Features vs. 2021-2022?
Sep 9, 2025, 16:22 PM -
Bimekizumab Led to Sustained Improvements in Health-Related Quality of Life and Work Productivity in Patients With Axial Spondyloarthritis: 3-Year Results From Two Phase 3 Studies
Sep 9, 2025, 16:22 PM -
Regulatory Landscape Challenges and Trends in the Adoption of Digital Endpoints in Clinical Trials: A Scoping Review
Sep 9, 2025, 16:22 PM -
Economic Evaluation of a Booster Dose of TDaP Vaccine to Adolescents in Spain
Sep 9, 2025, 16:22 PM -
Budget Impact Minimization Approaches Used Across Europe, Brazil, and Japan in the Reimbursement of Obesity Medications
Sep 9, 2025, 16:22 PM -
Cost Effectiveness and Budget Impact Analysis of Benralizumab for Treating Severe Uncontrolled Eosinophilic Asthma in Egypt
Sep 9, 2025, 16:22 PM